Loading, please wait....jpg)
.jpg)
The Premier August 13, 2025 CE webinar will be held from 1 - 2 pm EDT. We are pleased to provide one (1) 60-minute knowledge-based, ACPE-accredited CE activity to pharmacists and pharmacy technicians.
Biosimilars - The 2025 Update
Speaker: Liya Davydov, PharmD, BCPS, BCGP, Senior Director, Clinical Pharmacy Services, Premier Continuum of Care, Charlotte, NC
ACPE Universal Activity Number: 0122-0000-25-044-L01-P/T [0.1 CEU] [1 Contact Hr.]
Date: Aug 13, 2025 01:00 PM - 02:00 PM
Fee
$0.00
CE Hours
1.00
CE Units
0.100
Registration closes on Aug 13, 2025 01:10 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists and Pharmacy Technicians
Accreditation(s)
|
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
CE participation will be provided to CPE Monitor within 45 days of the CE activity upon CE registration, confirmation of participation for the entire activity, and completion of online learning assessment questions and speaker evaluation administered post-session.
Support/Credits
Financial support: Premier, Inc. has received no outside support for the administration of this program.
Objectives
- Describe growth trends of biosimilar agents in the pharmaceutical pipeline
- Identify biosimilar agents that have been recently approved, rejected, or are currently under regulatory review
- List various reimbursement models/strategies for biosimilars
Speaker(s)/Author(s)
|
Liya Davydov, PharmD, BCPS, BCGP
|
Activity Number
0122-0000-25-044-L01-P/T
Date:
08/13/25
Time:
01:00 PM - 02:00 PM
CE Hours
1.00